The advancement of cancer therapy has seen a significant shift towards targeted treatments that specifically inhibit key pathways involved in cancer cell growth and proliferation. Palbociclib, a groundbreaking drug that inhibits cyclin-dependent kinases (CDKs) 4 and 6, is a prime example of this paradigm. The synthesis of such sophisticated molecules relies on high-quality chemical intermediates, including 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one (CAS: 1016636-76-2).
This intermediate is crucial because it forms a core structural component of Palbociclib. For pharmaceutical companies and researchers focused on oncology, understanding the importance of this compound is key to driving their therapeutic development forward. When you aim to buy 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one, you are essentially acquiring a vital piece for building a life-saving medication.
The selection of a reliable Palbociclib intermediate supplier in China or elsewhere is critical. The quality of this intermediate directly influences the efficacy and safety profile of the final Palbociclib API. Therefore, a high degree of purity is non-negotiable. Pharmaceutical manufacturers must ensure that the intermediates they procure meet rigorous quality standards, often exceeding 99% purity, to guarantee the integrity of their drug products.
When considering the CAS 1016636-76-2 price, it’s important to view it as an investment in patient safety and therapeutic effectiveness. A competent pharmaceutical intermediate manufacturer will provide the necessary analytical data and support to confirm the compound's suitability for pharmaceutical use. This commitment to quality assurance is a hallmark of reliable suppliers.
The demand for advanced intermediates like 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one highlights the innovation occurring in the pharmaceutical sector. As a high purity chemical compound for sale, it represents a critical link in the chain from chemical synthesis to clinical application. Researchers actively involved in drug discovery might also explore derivatives or related compounds synthesized from this intermediate to develop next-generation cancer therapies.
By ensuring a consistent and high-quality supply of this essential intermediate, pharmaceutical manufacturers can confidently advance their research and production efforts, ultimately contributing to improved patient outcomes in the fight against cancer. Exploring partnerships with experienced chemical suppliers is key to securing these vital components.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.